Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (4): 604-608    DOI: 10.31083/j.ejgo.2020.04.5208
Original Research Previous articles | Next articles
Effect of letrozole combined with testosterone on the proliferation and apoptosis of endometrial carcinoma cells
Di Wu1, Jirui Zhang1, Chengxi Yang2, *()
1Xuzhou Medical University, Lianyungang 222002, P. R. China
2Reproductive Center, Lianyungang Hospital Affiliated to Xuzhou Medical University, Lianyungang 222002, P. R. China
Download:  PDF(559KB)  ( 276 ) Full text   ( 10 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To investigate the effect of the androgen testosterone on Ishikawa endometrial cancer (EC) cells in the presence of the aromatase inhibitor letrozole. Methods: Cultured Ishikawa EC cells were divided into three treatment groups: testosterone plus letrozole, testosterone alone and letrozole alone. The respective groups were treated for 48 h with these agents at final concentrations of 0.5, 1, 1.5, 2 or 2.5 μmol/L. The effect of combined letrozole and testosterone treatment was determined by MTT assay and flow cytometry. The effects of combined treatment on cell proliferation and apoptosis were also measured, while the concentration of estrogen in the culture solution was measured after treatment at a concentration of 2.5 μmol/L. Results: Inhibition of proliferation in the testosterone plus letrozole group increased with the concentration of these agents, with maximal inhibition observed at 2.5 μmol/L. Similarly, the rate of apoptosis increased with increasing concentration in the combined testosterone plus letrozole group. The proliferation and apoptosis rates were different between the three different testosterone and letrozole groups, while the estrogen concentration of the testosterone plus letrozole group was significantly lower that of the testosterone group. Conclusion: The androgen testosterone has anti-proliferative and pro-apoptotic effects on EC cells.
Key words:  Endometrial cancer      Androgen      Antitumor      Proliferation      Apoptosis     
Submitted:  14 February 2019      Accepted:  03 June 2019      Published:  15 August 2020     
*Corresponding Author(s):  CHENGXI YANG     E-mail:  dryangchengxi@163.com

Cite this article: 

Di Wu, Jirui Zhang, Chengxi Yang. Effect of letrozole combined with testosterone on the proliferation and apoptosis of endometrial carcinoma cells. European Journal of Gynaecological Oncology, 2020, 41(4): 604-608.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.04.5208     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I4/604

[1] Yusuf Cakmak, Tufan Oge. The effect of age on prediction of concurrent endometrial cancer in patients with atypical endometrial hyperplasia[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 531-535.
[2] Xifang Lv, Amanguli, Ping Yang. The role of sodium hydrosulfide in the proliferation and apoptosis of exogenous SB203580 pre-treated human ovarian cancer cells[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 622-628.
[3] B.-H. Zhang, L. Li, J. Ji, J. Guo, X.-L. Zhou, H. Xu, F. Cao, X.-H. Tong. Prognostic value of Foxp3+ regulatory T cells in endometrial cancer: a meta-analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 339-342.
[4] F. Oyama, Y. Asano, H. Shimoda, K. Horie, J. Watanabe, Y. Yokoayama. Morphological analysis of peritoneal dissemination of ovarian cancer based on levels of carbonyl reductase 1 expression[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 352-360.
[5] Chen J.Y., Wang Z.Q., Liang S.C., Hou H.Y., Chen D.B., Wang J.L.. Sentinel lymph node mapping with carbon nanoparticles in endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 408-414.
[6] J. Feng, J. Wu, M. Zhang, J. Wang, K. Chen, X. Li, J. Xie, J. Zhang, C. Wang. Oleic acid promotes the development of endometrial cancer by up-regulating KLF4 expression[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 432-438.
[7] S. Liu, F. Ruan, M. Shi, Y. Liu, W. Li, B. Bi, H. Wang, W. Lv. Safe fertility-preserving management in a young woman with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 476-479.
[8] K. Plagens–Rotman, M. Piskorz–Szymendera, B. PIĘTA. Lifestyle with particular emphasis on physical activity and genital carcinomas in women[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 233-239.
[9] X.Q. Wang, S.Q. Ma, J.Y. Guo, F. Zhao, X.H. Liang. Characteristics and prognostic factors among premenopausal versus postmenopausal patients with advanced endometrial cancer: a SEER-based analysis[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 1-6.
[10] S. Srdelić Mihalj, V. Čapkun, I. Kuzmić-Prusac. High-grade endometrial cancer survival (endometrioid to non-endometrioid histology comparison)[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 16-22.
[11] Y.-S. Kwon, K. S. Im, S. B. Yoo, W. I. Kim. Two cases of uterus-conserving treatment for early stage endometrial cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 145-147.
[12] T. Wada, Y. Hashiguchi, M. Kasai, T. Fukuda, T. Ichimura, T. Yasui, T. Sumi. HMGCR antibody-associated myopathy in patient with endometrial cancer: a rare case[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 148-150.
[13] M. Englert-Golon, B. Burchardt, R. Słopień, N. Smolarek, S. Sajdak. Ovarian and endometrial cancer after breast cancer - three primary malignancies in a single patient[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 153-154.
[14] T. Tantitamit, K.-G. Huang, A. Temtanakitpaisan. Emerging role of sentinel lymph node mapping for gynecologic oncology in the new era[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 905-914.
[15] T. Tantitamit, K.-G. Huang. Sentinel lymph node biopsy in endometrial and cervical cancer: current and controversial issues[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 919-924.
No Suggested Reading articles found!